Copyright
©The Author(s) 2019.
World J Hepatol. Oct 27, 2019; 11(10): 710-718
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.710
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.710
Figure 1 The prevalence of advanced fibrosis in patients with non-alcoholic fatty liver disease (1.
7%) and both alcoholic and non-alcoholic fatty liver disease (7.1%). Patients with BAFLD have 3-fold increase in the prevalence of advanced fibrosis. NAFLD: Non-alcoholic fatty liver disease; BAFLD: Both alcoholic and non-alcoholic fatty liver disease; AF: Advanced fibrosis.
- Citation: Khoudari G, Singh A, Noureddin M, Fritze D, Lopez R, Asaad I, Lawitz E, Poordad F, Kowdley KV, Alkhouri N. Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort. World J Hepatol 2019; 11(10): 710-718
- URL: https://www.wjgnet.com/1948-5182/full/v11/i10/710.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i10.710